Biotechnology
The Biotechnology industry has a total of 639 stocks, with a combined market cap of $853.67 billion and total revenue of $97.87 billion.
Market Cap
853.67B
Revenue
97.87B
Profits
-44.71B
PE Ratio
n/a
Profit Margin
-45.68%
Dividend Yield
0.05%
639 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.87B | -1.03% | 93,482 | 11.10B |
2 | REGN | Regeneron Pharmaceuticals, Inc. | 58.81B | -0.57% | 33,863 | 14.09B |
3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.72B | -0.82% | 67,771 | 2.35B |
4 | ARGX | argenx SE | 34.72B | -1.12% | 22,318 | 2.64B |
5 | ONC | BeOne Medicines Ltd. | 29.79B | -0.75% | 3,211 | 4.18B |
6 | BNTX | BioNTech SE | 27.94B | -0.40% | 19,271 | 2.97B |
7 | RPRX | Royalty Pharma plc | 20.19B | -0.58% | 65,885 | 2.26B |
8 | SMMT | Summit Therapeutics Inc. | 18.77B | -2.34% | 225,988 | - |
9 | INSM | Insmed Incorporated | 18.55B | 1.02% | 59,198 | 381.03M |
10 | GMAB | Genmab A/S | 13.43B | -0.96% | 66,771 | 3.23B |
11 | INCY | Incyte Corporation | 13.32B | -2.18% | 33,727 | 4.41B |
12 | MRNA | Moderna, Inc. | 12.97B | -2.16% | 899,036 | 3.18B |
13 | EXEL | Exelixis, Inc. | 12.27B | -0.38% | 73,701 | 2.30B |
14 | BMRN | BioMarin Pharmaceutical Inc. | 11.16B | -1.05% | 56,319 | 2.95B |
15 | ASND | Ascendis Pharma A/S | 10.64B | -0.47% | 17,660 | 398.51M |
16 | VRNA | Verona Pharma plc | 9.56B | 0.01% | 2,536,308 | 118.54M |
17 | BBIO | BridgeBio Pharma, Inc. | 8.74B | -0.48% | 33,086 | 127.42M |
18 | TECH | Bio-Techne Corporation | 8.43B | -1.18% | 18,068 | 1.21B |
19 | BPMC | Blueprint Medicines Corporation | 8.37B | - | 279,466 | 562.12M |
20 | ROIV | Roivant Sciences Ltd. | 7.82B | -0.61% | 194,591 | 29.05M |
21 | CORT | Corcept Therapeutics Incorporated | 7.58B | -0.67% | 19,777 | 685.45M |
22 | CAI | Caris Life Sciences, Inc. | 7.33B | -0.98% | 3,268 | 452.50M |
23 | LEGN | Legend Biotech Corporation | 7.25B | -0.98% | 10,757 | 728.30M |
24 | RVMD | Revolution Medicines, Inc. | 7.13B | -0.57% | 8,510 | - |
25 | HALO | Halozyme Therapeutics, Inc. | 7.02B | -1.09% | 20,696 | 1.08B |
26 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.95B | -0.51% | 6,111 | 317.38M |
27 | JAZZ | Jazz Pharmaceuticals plc | 6.72B | -1.30% | 6,559 | 4.06B |
28 | IONS | Ionis Pharmaceuticals, Inc. | 6.64B | -1.63% | 35,541 | 717.25M |
29 | NUVL | Nuvalent, Inc. | 5.88B | -0.18% | 17,557 | - |
30 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.70B | 0.62% | 18,193 | 136.86M |
31 | TGTX | TG Therapeutics, Inc. | 5.48B | -0.32% | 46,337 | 386.39M |
32 | AXSM | Axsome Therapeutics, Inc. | 5.47B | -0.01% | 25,661 | 432.16M |
33 | CRSP | CRISPR Therapeutics AG | 5.40B | -0.16% | 274,456 | 37.68M |
34 | TLX | Telix Pharmaceuticals Limited | 5.35B | -1.49% | 511 | 484.69M |
35 | PCVX | Vaxcyte, Inc. | 4.63B | -1.02% | 9,667 | - |
36 | ADMA | ADMA Biologics, Inc. | 4.41B | - | 49,017 | 459.38M |
37 | CYTK | Cytokinetics, Incorporated | 4.33B | -0.98% | 35,113 | 19.22M |
38 | KRYS | Krystal Biotech, Inc. | 4.25B | -1.70% | 3,146 | 333.45M |
39 | AKRO | Akero Therapeutics, Inc. | 4.12B | -0.58% | 23,523 | - |
40 | SLNO | Soleno Therapeutics, Inc. | 4.11B | 1.42% | 159,297 | - |
41 | MRUS | Merus N.V. | 4.06B | -1.13% | 10,753 | 54.73M |
42 | PTCT | PTC Therapeutics, Inc. | 3.87B | -1.37% | 23,185 | 1.77B |
43 | RNA | Avidity Biosciences, Inc. | 3.85B | 1.49% | 144,966 | 8.93M |
44 | ACLX | Arcellx, Inc. | 3.77B | -0.65% | 8,072 | 76.81M |
45 | MTSR | Metsera, Inc. | 3.74B | -2.16% | 18,331 | - |
46 | ZLAB | Zai Lab Limited | 3.69B | -2.13% | 26,971 | 418.33M |
47 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | -1.34% | 47,661 | 996.28M |
48 | SRRK | Scholar Rock Holding Corporation | 3.56B | -1.57% | 42,380 | - |
49 | VKTX | Viking Therapeutics, Inc. | 3.45B | -1.85% | 231,513 | - |
50 | AAPG | Ascentage Pharma Group International | 3.34B | -3.73% | 96 | 134.35M |
51 | PTGX | Protagonist Therapeutics, Inc. | 3.25B | -0.87% | 16,885 | 207.80M |
52 | KYMR | Kymera Therapeutics, Inc. | 3.14B | -0.88% | 7,912 | 58.89M |
53 | MLTX | MoonLake Immunotherapeutics | 3.12B | 0.65% | 20,152 | - |
54 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.99B | -0.17% | 20,787 | 760.00K |
55 | IMVT | Immunovant, Inc. | 2.96B | -0.97% | 20,178 | - |
56 | RARE | Ultragenyx Pharmaceutical Inc. | 2.89B | -1.34% | 251,533 | 590.69M |
57 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.69B | 0.78% | 78,449 | 534.65M |
58 | MIRM | Mirum Pharmaceuticals, Inc. | 2.61B | -0.52% | 16,552 | 379.25M |
59 | IBRX | ImmunityBio, Inc. | 2.60B | 2.79% | 663,753 | 31.22M |
60 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.57B | -1.27% | 25,846 | 545.21M |
61 | XENE | Xenon Pharmaceuticals Inc. | 2.51B | -0.80% | 9,373 | 7.50M |
62 | NAMS | NewAmsterdam Pharma Company N.V. | 2.47B | -0.09% | 12,600 | 47.14M |
63 | APLS | Apellis Pharmaceuticals, Inc. | 2.43B | -0.82% | 43,253 | 775.84M |
64 | RXRX | Recursion Pharmaceuticals, Inc. | 2.37B | -4.64% | 3,266,168 | 59.79M |
65 | AGIO | Agios Pharmaceuticals, Inc. | 2.29B | 0.13% | 38,105 | 37.04M |
66 | APGE | Apogee Therapeutics, Inc. | 2.24B | -0.57% | 49,980 | - |
67 | DNLI | Denali Therapeutics Inc. | 2.21B | -0.85% | 38,766 | - |
68 | BEAM | Beam Therapeutics Inc. | 2.14B | -0.14% | 148,437 | 63.58M |
69 | CGON | CG Oncology, Inc. | 2.05B | -0.85% | 11,100 | 662.00K |
70 | VCEL | Vericel Corporation | 2.03B | -2.07% | 14,164 | 238.54M |
71 | BLTE | Belite Bio, Inc | 2.01B | -0.39% | 765 | - |
72 | IDYA | IDEAYA Biosciences, Inc. | 2.01B | 0.48% | 15,088 | 7.00M |
73 | GLPG | Galapagos NV | 2.00B | -0.23% | 14,481 | 311.49M |
74 | IRON | Disc Medicine, Inc. | 1.97B | -1.86% | 35,041 | - |
75 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -0.06% | 21,389 | 744.85M |
76 | CNTA | Centessa Pharmaceuticals plc | 1.95B | -0.14% | 17,325 | 15.00M |
77 | FOLD | Amicus Therapeutics, Inc. | 1.92B | -1.27% | 74,147 | 543.14M |
78 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -2.70% | 341,003 | 2.23B |
79 | ADPT | Adaptive Biotechnologies Corporation | 1.81B | -1.57% | 205,476 | 189.53M |
80 | OCUL | Ocular Therapeutix, Inc. | 1.79B | 1.67% | 117,635 | 59.65M |
81 | ARQT | Arcutis Biotherapeutics, Inc. | 1.78B | -2.42% | 62,807 | 212.82M |
82 | IMCR | Immunocore Holdings plc | 1.76B | -1.28% | 1,389 | 333.58M |
83 | SPRY | ARS Pharmaceuticals, Inc. | 1.76B | -0.61% | 24,183 | 97.12M |
84 | COGT | Cogent Biosciences, Inc. | 1.72B | -1.47% | 88,733 | - |
85 | TARS | Tarsus Pharmaceuticals, Inc. | 1.68B | -2.75% | 8,204 | 233.67M |
86 | ETNB | 89bio, Inc. | 1.56B | -0.74% | 16,697 | - |
87 | PROK | ProKidney Corp. | 1.55B | 2.32% | 3,429,706 | 306.00K |
88 | JANX | Janux Therapeutics, Inc. | 1.53B | 1.13% | 75,665 | 9.34M |
89 | VERA | Vera Therapeutics, Inc. | 1.53B | -1.40% | 26,100 | - |
90 | CLDX | Celldex Therapeutics, Inc. | 1.51B | 0.18% | 10,354 | 7.56M |
91 | BHVN | Biohaven Ltd. | 1.47B | -4.26% | 25,236 | - |
92 | TVTX | Travere Therapeutics, Inc. | 1.45B | -1.21% | 15,194 | 273.53M |
93 | EWTX | Edgewise Therapeutics, Inc. | 1.43B | -1.95% | 7,605 | - |
94 | VRDN | Viridian Therapeutics, Inc. | 1.39B | -0.53% | 10,120 | 302.00K |
95 | MESO | Mesoblast Limited | 1.39B | -0.64% | 10,485 | 5.67M |
96 | ELVN | Enliven Therapeutics, Inc. | 1.36B | 0.92% | 10,040 | - |
97 | DYN | Dyne Therapeutics, Inc. | 1.24B | -0.45% | 48,991 | - |
98 | NTLA | Intellia Therapeutics, Inc. | 1.24B | -1.64% | 234,701 | 45.57M |
99 | ABCL | AbCellera Biologics Inc. | 1.23B | -3.06% | 432,820 | 23.11M |
100 | CVAC | CureVac N.V. | 1.22B | -0.55% | 65,240 | 566.04M |
101 | LQDA | Liquidia Corporation | 1.21B | -0.07% | 66,208 | 14.14M |
102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.21B | 0.11% | 78,254 | 247.30M |
103 | WVE | Wave Life Sciences Ltd. | 1.20B | -2.14% | 46,403 | 104.94M |
104 | INVA | Innoviva, Inc. | 1.20B | -0.03% | 50,157 | 369.84M |
105 | MNKD | MannKind Corporation | 1.15B | -0.66% | 75,577 | 297.60M |
106 | PHVS | Pharvaris N.V. | 1.13B | 4.44% | 6,242 | - |
107 | NVAX | Novavax, Inc. | 1.13B | -2.11% | 342,367 | 1.25B |
108 | CDTX | Cidara Therapeutics, Inc. | 1.12B | -0.24% | 23,648 | 302.00K |
109 | GPCR | Structure Therapeutics Inc. | 1.10B | 1.48% | 30,085 | - |
110 | ARDX | Ardelyx, Inc. | 1.10B | -2.13% | 116,091 | 361.71M |
111 | PRAX | Praxis Precision Medicines, Inc. | 1.03B | 0.83% | 11,533 | 8.12M |
112 | ZYME | Zymeworks Inc. | 1.02B | 0.07% | 6,823 | 93.38M |
113 | OCS | Oculis Holding AG | 1.00B | -0.27% | 3,044 | 847.33K |
114 | RCUS | Arcus Biosciences, Inc. | 992.67M | -1.73% | 25,439 | 141.00M |
115 | VERV | Verve Therapeutics, Inc. | 989.68M | 0.18% | 210,221 | 59.61M |
116 | MDXG | MiMedx Group, Inc. | 986.65M | -1.47% | 14,145 | 352.38M |
117 | GHRS | GH Research PLC | 974.77M | -2.09% | 25,504 | - |
118 | NRIX | Nurix Therapeutics, Inc. | 967.85M | -0.08% | 42,973 | 88.38M |
119 | LENZ | LENZ Therapeutics, Inc. | 963.30M | -0.10% | 7,712 | - |
120 | ORIC | ORIC Pharmaceuticals, Inc. | 954.94M | -2.14% | 20,903 | - |
121 | MLYS | Mineralys Therapeutics, Inc. | 953.51M | -0.07% | 9,067 | - |
122 | AVXL | Anavex Life Sciences Corp. | 948.48M | -0.63% | 36,212 | - |
123 | SANA | Sana Biotechnology, Inc. | 942.82M | 2.96% | 384,301 | - |
124 | SYRE | Spyre Therapeutics, Inc. | 941.52M | -2.26% | 2,289 | - |
125 | NAGE | Niagen Bioscience, Inc. | 930.66M | - | 35,654 | 107.93M |
126 | SION | Sionna Therapeutics, Inc. | 920.20M | -0.33% | 251 | - |
127 | GERN | Geron Corporation | 875.76M | -0.36% | 336,287 | 116.29M |
128 | CRMD | CorMedix Inc. | 862.63M | -1.02% | 59,093 | 82.55M |
129 | REPL | Replimune Group, Inc. | 846.41M | 1.95% | 142,522 | - |
130 | SNDX | Syndax Pharmaceuticals, Inc. | 833.80M | -1.32% | 77,870 | 43.72M |
131 | XERS | Xeris Biopharma Holdings, Inc. | 831.20M | -1.52% | 27,683 | 222.55M |
132 | VIR | Vir Biotechnology, Inc. | 805.93M | -1.69% | 119,840 | 20.86M |
133 | QURE | uniQure N.V. | 802.07M | -1.55% | 13,317 | 20.20M |
134 | AVBP | ArriVent BioPharma, Inc. | 798.41M | -0.77% | 3,301 | - |
135 | NUVB | Nuvation Bio Inc. | 775.80M | -1.30% | 366,130 | 10.96M |
136 | ANAB | AnaptysBio, Inc. | 768.30M | 0.23% | 5,369 | 111.87M |
137 | IMNM | Immunome, Inc. | 763.97M | -1.90% | 15,896 | 10.94M |
138 | TRVI | Trevi Therapeutics, Inc. | 761.34M | -0.31% | 40,979 | - |
139 | EYPT | EyePoint Pharmaceuticals, Inc. | 750.05M | -1.45% | 25,812 | 56.04M |
140 | IMTX | Immatics N.V. | 734.16M | 0.67% | 9,255 | 155.80M |
141 | MRVI | Maravai LifeSciences Holdings, Inc. | 719.41M | -2.25% | 37,160 | 241.86M |
142 | DAWN | Day One Biopharmaceuticals, Inc. | 717.14M | -1.60% | 27,659 | 161.92M |
143 | PHAR | Pharming Group N.V. | 705.89M | 0.30% | 1,000 | 320.71M |
144 | KALV | KalVista Pharmaceuticals, Inc. | 701.15M | -9.16% | 265,148 | - |
145 | GYRE | Gyre Therapeutics, Inc. | 697.15M | -1.54% | 874 | 100.64M |
146 | MAZE | Maze Therapeutics, Inc. | 693.75M | 1.28% | 3,840 | 167.50M |
147 | MGTX | MeiraGTx Holdings plc | 683.91M | -1.28% | 61,321 | 34.51M |
148 | PHAT | Phathom Pharmaceuticals, Inc. | 671.76M | -0.46% | 8,462 | 81.86M |
149 | URGN | UroGen Pharma Ltd. | 667.17M | -1.16% | 31,837 | 91.87M |
150 | ZVRA | Zevra Therapeutics, Inc. | 664.08M | 1.04% | 94,445 | 40.59M |
151 | DNTH | Dianthus Therapeutics, Inc. | 659.28M | -0.53% | 9,270 | 6.52M |
152 | AUTL | Autolus Therapeutics plc | 654.71M | -0.81% | 48,373 | 9.01M |
153 | STOK | Stoke Therapeutics, Inc. | 650.80M | -1.00% | 6,845 | 190.91M |
154 | AMLX | Amylyx Pharmaceuticals, Inc. | 650.73M | -1.22% | 31,444 | -1.27M |
155 | XNCR | Xencor, Inc. | 643.38M | -2.59% | 8,746 | 127.23M |
156 | TNGX | Tango Therapeutics, Inc. | 640.61M | -3.27% | 41,173 | 40.99M |
157 | IOVA | Iovance Biotherapeutics, Inc. | 632.81M | -1.81% | 439,709 | 212.68M |
158 | RLAY | Relay Therapeutics, Inc. | 626.63M | -2.01% | 92,041 | 7.68M |
159 | UPB | Upstream Bio, Inc. | 624.54M | -1.94% | 824 | 2.30M |
160 | ABUS | Arbutus Biopharma Corporation | 610.97M | -2.74% | 39,398 | 6.40M |
161 | DNA | Ginkgo Bioworks Holdings, Inc. | 608.73M | -3.61% | 113,704 | 237.42M |
162 | MNMD | Mind Medicine (MindMed) Inc. | 602.16M | -1.60% | 31,817 | - |
163 | KROS | Keros Therapeutics, Inc. | 586.08M | -0.28% | 30,105 | 214.71M |
164 | SAGE | Sage Therapeutics, Inc. | 577.38M | 0.11% | 78,970 | 47.40M |
165 | ATAI | Atai Life Sciences N.V. | 577.03M | -0.37% | 241,082 | 1.86M |
166 | ARVN | Arvinas, Inc. | 572.25M | -0.63% | 46,217 | 426.90M |
167 | TBPH | Theravance Biopharma, Inc. | 569.52M | -0.61% | 1,644 | 65.27M |
168 | PGEN | Precigen, Inc. | 563.79M | - | 70,652 | 4.20M |
169 | TSHA | Taysha Gene Therapies, Inc. | 563.49M | 2.94% | 499,623 | 7.22M |
170 | BCYC | Bicycle Therapeutics plc | 560.44M | 0.03% | 5,970 | 25.72M |
171 | RAPP | Rapport Therapeutics, Inc. | 558.78M | -0.46% | 1,096 | - |
172 | TYRA | Tyra Biosciences, Inc. | 544.85M | 0.06% | 3,887 | - |
173 | PRME | Prime Medicine, Inc. | 538.50M | -12.37% | 1,056,544 | 3.85M |
174 | KURA | Kura Oncology, Inc. | 537.63M | -2.36% | 45,140 | 67.99M |
175 | ORKA | Oruka Therapeutics, Inc. | 525.29M | -0.28% | 7,121 | - |
176 | BCAX | Bicara Therapeutics Inc. | 525.18M | -2.92% | 10,445 | - |
177 | ABVX | ABIVAX Société Anonyme | 523.74M | -0.84% | 29,498 | 11.44M |
178 | SEPN | Septerna, Inc. | 523.11M | 0.51% | 4,794 | 977.00K |
179 | CELC | Celcuity Inc. | 513.09M | -0.51% | 1,585 | - |
180 | VALN | Valneva SE | 506.85M | -0.36% | 463 | 201.10M |
181 | ZBIO | Zenas BioPharma, Inc. | 490.51M | -2.86% | 7,328 | 15.00M |
182 | SVRA | Savara Inc. | 484.59M | - | 40,259 | - |
183 | ATYR | aTyr Pharma, Inc. | 474.84M | 0.09% | 527,868 | 235.00K |
184 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
185 | FTRE | Fortrea Holdings Inc. | 459.49M | -3.70% | 48,088 | 2.69B |
186 | CGEM | Cullinan Therapeutics, Inc. | 457.95M | -1.02% | 5,757 | - |
187 | RGNX | REGENXBIO Inc. | 454.00M | -0.55% | 7,977 | 156.72M |
188 | IVA | Inventiva S.A. | 450.35M | 1.78% | 17,295 | 14.59M |
189 | TRML | Tourmaline Bio, Inc. | 441.58M | -1.04% | 2,910 | - |
190 | RZLT | Rezolute, Inc. | 437.94M | -2.46% | 15,900 | - |
191 | PRTC | PureTech Health plc | 432.70M | -3.40% | - | 4.83M |
192 | NKTR | Nektar Therapeutics | 432.53M | -0.40% | 67,628 | 87.25M |
193 | FULC | Fulcrum Therapeutics, Inc. | 431.83M | -0.12% | 5,098 | 80.00M |
194 | ERAS | Erasca, Inc. | 427.76M | -0.66% | 17,283 | - |
195 | AURA | Aura Biosciences, Inc. | 416.67M | -0.74% | 1,427 | - |
196 | TERN | Terns Pharmaceuticals, Inc. | 413.98M | -2.67% | 48,625 | - |
197 | SLDB | Solid Biosciences Inc. | 410.83M | -2.21% | 47,519 | - |
198 | MBX | MBX Biosciences, Inc. | 407.78M | -1.61% | 15,903 | - |
199 | TECX | Tectonic Therapeutic, Inc. | 396.32M | -2.28% | 4,415 | - |
200 | LXRX | Lexicon Pharmaceuticals, Inc. | 395.86M | -3.54% | 195,035 | 31.21M |
201 | CTMX | CytomX Therapeutics, Inc. | 395.44M | -3.46% | 95,139 | 147.56M |
202 | ITOS | iTeos Therapeutics, Inc. | 389.63M | -0.29% | 21,705 | 35.00M |
203 | CMPX | Compass Therapeutics, Inc. | 386.50M | -1.93% | 148,028 | 850.00K |
204 | ARCT | Arcturus Therapeutics Holdings Inc. | 386.47M | -1.59% | 8,766 | 143.68M |
205 | VIGL | Vigil Neuroscience, Inc. | 383.80M | 0.12% | 7,932 | - |
206 | ATXS | Astria Therapeutics, Inc. | 379.24M | 0.75% | 9,445 | - |
207 | CAPR | Capricor Therapeutics, Inc. | 373.43M | -28.33% | 8,847,397 | 17.36M |
208 | BNTC | Benitec Biopharma Inc. | 363.57M | 0.44% | 650 | - |
209 | HUMA | Humacyte, Inc. | 355.22M | -8.76% | 963,145 | 517.00K |
210 | ADCT | ADC Therapeutics SA | 354.76M | -4.19% | 25,629 | 75.82M |
211 | ALT | Altimmune, Inc. | 351.60M | -1.48% | 489,628 | 20.00K |
212 | PRTA | Prothena Corporation plc | 346.11M | -2.13% | 37,043 | 137.94M |
213 | RNAC | Cartesian Therapeutics, Inc. | 345.71M | -1.62% | 4,136 | 34.17M |
214 | ABSI | Absci Corporation | 341.86M | -1.83% | 400,254 | 4.82M |
215 | OCGN | Ocugen, Inc. | 341.68M | 1.74% | 942,407 | 4.52M |
216 | RIGL | Rigel Pharmaceuticals, Inc. | 341.36M | -2.55% | 5,121 | 203.08M |
217 | HRTX | Heron Therapeutics, Inc. | 335.64M | -0.90% | 105,987 | 148.52M |
218 | JBIO | Jade Biosciences, Inc. | 334.93M | -1.24% | 1,405 | - |
219 | RCKT | Rocket Pharmaceuticals, Inc. | 333.99M | -1.90% | 90,889 | - |
220 | XOMA | XOMA Royalty Corporation | 331.96M | -0.57% | 288 | 42.91M |
221 | OLMA | Olema Pharmaceuticals, Inc. | 325.69M | -1.86% | 7,374 | - |
222 | CRVS | Corvus Pharmaceuticals, Inc. | 324.27M | -1.06% | 4,801 | - |
223 | AVIR | Atea Pharmaceuticals, Inc. | 322.21M | -0.40% | 23,721 | - |
224 | GLUE | Monte Rosa Therapeutics, Inc. | 318.62M | -1.52% | 8,879 | 159.49M |
225 | GOSS | Gossamer Bio, Inc. | 314.81M | 1.84% | 44,827 | 124.59M |
226 | SGMT | Sagimet Biosciences Inc. | 314.55M | -1.41% | 57,396 | - |
227 | VOR | Vor Biopharma Inc. | 306.78M | 6.28% | 2,011,651 | - |
228 | TNXP | Tonix Pharmaceuticals Holding Corp. | 306.75M | -2.22% | 31,405 | 10.04M |
229 | DBVT | DBV Technologies S.A. | 304.94M | 2.27% | 403 | 3.50M |
230 | CADL | Candel Therapeutics, Inc. | 304.12M | -1.30% | 45,312 | - |
231 | NGNE | Neurogene Inc. | 302.78M | -3.32% | 4,267 | 925.00K |
232 | INBX | Inhibrx Biosciences, Inc. | 296.47M | -2.38% | 1,379 | 200.00K |
233 | FHTX | Foghorn Therapeutics Inc. | 294.87M | -2.04% | 379 | 23.50M |
234 | ABEO | Abeona Therapeutics Inc. | 294.15M | -1.71% | 28,274 | - |
235 | PVLA | Palvella Therapeutics, Inc. | 293.75M | -1.37% | 3,001 | - |
236 | ANNX | Annexon, Inc. | 291.84M | -5.00% | 262,069 | - |
237 | SLN | Silence Therapeutics plc | 291.36M | -3.91% | 7,132 | 27.70M |
238 | VNDA | Vanda Pharmaceuticals Inc. | 289.37M | -1.60% | 15,271 | 201.35M |
239 | ALDX | Aldeyra Therapeutics, Inc. | 285.70M | -0.63% | 82,877 | - |
240 | ALLO | Allogene Therapeutics, Inc. | 284.35M | 3.17% | 457,390 | 22.00K |
241 | CRDF | Cardiff Oncology, Inc. | 279.74M | 1.08% | 40,748 | 587.00K |
242 | AARD | Aardvark Therapeutics, Inc. | 274.45M | 0.40% | 1,089 | - |
243 | MREO | Mereo BioPharma Group plc | 269.51M | 0.30% | 1,352,882 | 1.00M |
244 | DRTS | Alpha Tau Medical Ltd. | 264.26M | -0.95% | 289 | - |
245 | VSTM | Verastem, Inc. | 257.71M | -1.05% | 73,897 | 10.00M |
246 | NBTX | Nanobiotix S.A. | 256.80M | -1.72% | 435 | -7.44M |
247 | FENC | Fennec Pharmaceuticals Inc. | 251.61M | 0.77% | 33,994 | 30.91M |
248 | CDXS | Codexis, Inc. | 250.19M | -2.89% | 22,848 | 49.82M |
249 | EDIT | Editas Medicine, Inc. | 246.95M | -3.59% | 112,139 | 35.84M |
250 | THRD | Third Harmonic Bio, Inc. | 245.95M | - | 4,081 | - |
251 | NVCT | Nuvectis Pharma, Inc. | 244.65M | - | 180 | - |
252 | PRQR | ProQR Therapeutics N.V. | 244.40M | -1.69% | 13,528 | 21.21M |
253 | OABI | OmniAb, Inc. | 244.06M | -3.16% | 37,630 | 26.74M |
254 | LXEO | Lexeo Therapeutics, Inc. | 243.53M | -1.74% | 5,516 | - |
255 | SCPH | scPharmaceuticals Inc. | 236.51M | 0.22% | 16,754 | 41.98M |
256 | MNPR | Monopar Therapeutics Inc. | 235.77M | 0.77% | 329 | - |
257 | TENX | Tenax Therapeutics, Inc. | 234.16M | 2.18% | 1,392 | - |
258 | LCTX | Lineage Cell Therapeutics, Inc. | 232.92M | - | 148,898 | 9.56M |
259 | TRDA | Entrada Therapeutics, Inc. | 231.28M | -2.96% | 14,774 | 172.22M |
260 | IMMP | Immutep Limited | 230.04M | 3.05% | 3,072 | 3.02M |
261 | KOD | Kodiak Sciences Inc. | 229.99M | -2.67% | 2,229 | - |
262 | MDWD | MediWound Ltd. | 227.93M | - | 88 | 19.21M |
263 | TVGN | Tevogen Bio Holdings Inc. | 224.10M | -0.41% | 10,379 | - |
264 | TVRD | Tvardi Therapeutics, Inc. | 219.79M | 3.57% | 18,508 | - |
265 | DSGN | Design Therapeutics, Inc. | 219.69M | -4.21% | 1,262 | - |
266 | LRMR | Larimar Therapeutics, Inc. | 215.13M | -3.45% | 39,187 | - |
267 | CRGX | CARGO Therapeutics, Inc. | 213.75M | -0.11% | 48,609 | - |
268 | OMER | Omeros Corporation | 210.93M | 4.05% | 81,933 | - |
269 | ACIU | AC Immune SA | 206.79M | -0.95% | 12,371 | 32.01M |
270 | ELDN | Eledon Pharmaceuticals, Inc. | 204.20M | -1.16% | 5,314 | - |
271 | CBIO | Crescent Biopharma, Inc. | 201.05M | -0.41% | 9,400 | - |
272 | EPRX | Eupraxia Pharmaceuticals Inc. | 199.87M | -1.75% | 1,008 | - |
273 | YMAB | Y-mAbs Therapeutics, Inc. | 199.79M | -2.42% | 5,594 | 88.66M |
274 | VTYX | Ventyx Biosciences, Inc. | 199.25M | -1.41% | 76,332 | - |
275 | FDMT | 4D Molecular Therapeutics, Inc. | 198.27M | -1.61% | 3,277 | 23.00K |
276 | VYGR | Voyager Therapeutics, Inc. | 197.55M | 0.56% | 95,975 | 66.96M |
277 | ALMS | Alumis Inc. | 196.68M | 1.54% | 30,738 | 17.39M |
278 | GNFT | Genfit S.A. | 192.99M | 0.27% | 1,001 | 73.19M |
279 | ENGNW | enGene Holdings Inc. | 188.07M | - | 11 | - |
280 | SLS | SELLAS Life Sciences Group, Inc. | 186.09M | -1.58% | 255,140 | - |
281 | LIMN | Liminatus Pharma, Inc. | 184.96M | -1.25% | 34,241 | - |
282 | ENGN | enGene Holdings Inc. | 182.96M | -2.72% | 1,008 | - |
283 | AGEN | Agenus Inc. | 181.77M | 11.99% | 322,504 | 99.52M |
284 | DRUG | Bright Minds Biosciences Inc. | 180.95M | -3.20% | 368 | - |
285 | ACOG | Alpha Cognition Inc. | 179.27M | 1.73% | 455 | 2.93M |
286 | IMAB | I-Mab | 177.73M | 6.17% | 56,218 | 569.46K |
287 | CYBN | Cybin Inc. | 172.75M | -1.32% | 48,220 | - |
288 | ACRS | Aclaris Therapeutics, Inc. | 171.08M | -0.63% | 28,393 | 17.78M |
289 | PBYI | Puma Biotechnology, Inc. | 171.07M | -2.09% | 14,056 | 232.71M |
290 | ALEC | Alector, Inc. | 169.99M | -1.16% | 15,394 | 88.34M |
291 | TIL | Instil Bio, Inc. | 169.25M | -3.59% | 16,963 | - |
292 | NMRA | Neumora Therapeutics, Inc. | 166.60M | -2.83% | 61,444 | - |
293 | GALT | Galectin Therapeutics Inc. | 165.82M | 6.94% | 40,600 | - |
294 | IPHA | Innate Pharma S.A. | 162.87M | -6.07% | 961 | 20.83M |
295 | TLSA | Tiziana Life Sciences Ltd | 162.85M | -0.61% | 34,228 | - |
296 | IMRX | Immuneering Corporation | 161.58M | 3.70% | 89,690 | - |
297 | INKT | MiNK Therapeutics, Inc. | 160.74M | 421.73% | 7,950,487 | - |
298 | CGEN | Compugen Ltd. | 158.04M | - | 12,290 | 27.59M |
299 | SPRO | Spero Therapeutics, Inc. | 157.67M | -0.70% | 60,464 | 44.58M |
300 | DMAC | DiaMedica Therapeutics Inc. | 157.00M | -0.24% | 3,568 | - |
301 | CABA | Cabaletta Bio, Inc. | 156.50M | - | 51,613 | - |
302 | KYTX | Kyverna Therapeutics, Inc. | 156.02M | 1.12% | 93,156 | - |
303 | BDTX | Black Diamond Therapeutics, Inc. | 155.80M | - | 64,769 | 70.00M |
304 | CRBU | Caribou Biosciences, Inc. | 152.99M | -5.46% | 68,440 | 9.92M |
305 | ENTA | Enanta Pharmaceuticals, Inc. | 147.82M | -0.93% | 9,926 | 64.46M |
306 | GLSI | Greenwich LifeSciences, Inc. | 147.40M | -1.73% | 9,478 | - |
307 | CCCC | C4 Therapeutics, Inc. | 146.98M | 4.02% | 58,612 | 39.78M |
308 | IKT | Inhibikase Therapeutics, Inc. | 146.45M | -1.50% | 1,469 | 1.00 |
309 | LYEL | Lyell Immunopharma, Inc. | 145.42M | 0.51% | 2,040 | 65.00K |
310 | THTX | Theratechnologies Inc. | 144.81M | - | 107,869 | 84.38M |
311 | ASMB | Assembly Biosciences, Inc. | 139.31M | 0.11% | 309 | 32.15M |
312 | RAPT | RAPT Therapeutics, Inc. | 137.58M | -3.48% | 3,428 | - |
313 | MOLN | Molecular Partners AG | 135.29M | 1.12% | 160 | 2.53M |
314 | FBRX | Forte Biosciences, Inc. | 134.47M | -3.88% | 17,804 | - |
315 | ELTX | Elicio Therapeutics, Inc. | 132.18M | - | 3,135 | - |
316 | FATE | Fate Therapeutics, Inc. | 128.96M | -3.02% | 39,627 | 13.34M |
317 | VTVT | vTv Therapeutics Inc. | 128.69M | 2.63% | 383 | 17.00K |
318 | SEER | Seer, Inc. | 128.28M | -0.46% | 8,173 | 15.31M |
319 | NKTX | Nkarta, Inc. | 125.59M | -1.67% | 144,172 | - |
320 | KRRO | Korro Bio, Inc. | 125.36M | -1.77% | 1,639 | 4.82M |
321 | GNLX | Genelux Corporation | 124.96M | -2.62% | 12,785 | 8.00K |
322 | SKYE | Skye Bioscience, Inc. | 124.18M | 1.72% | 100,135 | - |
323 | CSBR | Champions Oncology, Inc. | 120.75M | - | 122 | 58.59M |
324 | TARA | Protara Therapeutics, Inc. | 119.22M | -0.96% | 6,754 | - |
325 | ACTU | Actuate Therapeutics, Inc. | 118.70M | -2.10% | 4,144 | - |
326 | SGMO | Sangamo Therapeutics, Inc. | 118.56M | -0.20% | 484,638 | 63.76M |
327 | ACHV | Achieve Life Sciences, Inc. | 117.82M | -1.72% | 14,953 | - |
328 | ATOS | Atossa Therapeutics, Inc. | 117.54M | 2.49% | 82,175 | - |
329 | PLX | Protalix BioTherapeutics, Inc. | 116.23M | -1.35% | 13,396 | 59.76M |
330 | HURA | TuHURA Biosciences, Inc. | 115.44M | -1.59% | 6,041 | - |
331 | TNYA | Tenaya Therapeutics, Inc. | 115.17M | 2.94% | 122,574 | - |
332 | MIST | Milestone Pharmaceuticals Inc. | 114.83M | -32.42% | 3,347,802 | - |
333 | CLLS | Cellectis S.A. | 112.54M | -2.42% | 1,101 | 54.75M |
334 | OBIO | Orchestra BioMed Holdings, Inc. | 112.26M | -2.33% | 12,617 | 2.89M |
335 | BMEA | Biomea Fusion, Inc. | 110.91M | 0.78% | 152,463 | - |
336 | OKYO | OKYO Pharma Limited | 110.78M | 3.50% | 12,647 | - |
337 | ONCY | Oncolytics Biotech Inc. | 106.59M | -3.14% | 62,793 | - |
338 | MCRB | Seres Therapeutics, Inc. | 105.49M | -2.19% | 4,388 | - |
339 | COYA | Coya Therapeutics, Inc. | 105.03M | -0.71% | 709 | 3.69M |
340 | SAVA | Cassava Sciences, Inc. | 103.86M | -0.46% | 40,074 | - |
341 | CHRS | Coherus Oncology, Inc. | 103.76M | 3.21% | 57,496 | 272.25M |
342 | HLVX | HilleVax, Inc. | 102.68M | -1.43% | 10,484 | - |
343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 102.12M | -0.18% | 3,226 | - |
344 | CTNM | Contineum Therapeutics, Inc. | 101.80M | -2.36% | 8,687 | - |
345 | TCRX | TScan Therapeutics, Inc. | 101.01M | -2.99% | 34,547 | 4.42M |
346 | ANIX | Anixa Biosciences, Inc. | 100.50M | -0.64% | 7,406 | - |
347 | MGNX | MacroGenics, Inc. | 98.11M | -1.58% | 48,882 | 154.05M |
348 | ZNTL | Zentalis Pharmaceuticals, Inc. | 96.42M | -2.19% | 14,216 | 26.87M |
349 | NAUT | Nautilus Biotechnology, Inc. | 94.56M | -0.32% | 9,787 | - |
350 | WHWK | Whitehawk Therapeutics, Inc. | 92.81M | - | 1,541 | 27.78M |
351 | CLYM | Climb Bio, Inc. | 92.58M | 1.48% | 2,274 | - |
352 | NTRB | Nutriband Inc. | 90.71M | -0.61% | 2,022 | 2.40M |
353 | IOBT | IO Biotech, Inc. | 90.26M | -2.14% | 17,010 | - |
354 | OTLK | Outlook Therapeutics, Inc. | 89.99M | 3.96% | 24,342 | - |
355 | XBIT | XBiotech Inc. | 89.94M | -0.34% | 1,937 | - |
356 | ADAG | Adagene Inc. | 89.74M | -1.80% | 244 | 103.20K |
357 | BYSI | BeyondSpring Inc. | 89.50M | -1.33% | 103 | 1.88M |
358 | VERU | Veru Inc. | 88.10M | 3.05% | 273,434 | 16.89M |
359 | NTHI | NeOnc Technologies Holdings, Inc. | 88.09M | -5.12% | 18,350 | 79.99K |
360 | IVVD | Invivyd, Inc. | 87.84M | -1.77% | 44,591 | 36.69M |
361 | ORMP | Oramed Pharmaceuticals Inc. | 87.83M | 1.42% | 1,761 | 2.00M |
362 | QNCX | Quince Therapeutics, Inc. | 86.68M | 7.10% | 33,631 | - |
363 | PLRX | Pliant Therapeutics, Inc. | 86.55M | 0.71% | 19,381 | - |
364 | ZURA | Zura Bio Limited | 86.01M | - | 12,453 | - |
365 | EXOZ | eXoZymes, Inc. | 84.51M | 0.80% | 3 | -700.00 |
366 | ENTX | Entera Bio Ltd. | 83.06M | -0.68% | 324 | 223.00K |
367 | ARMP | Armata Pharmaceuticals, Inc. | 82.88M | 0.88% | 261 | 4.70M |
368 | ABOS | Acumen Pharmaceuticals, Inc. | 81.77M | 3.85% | 180,347 | - |
369 | VXRT | Vaxart, Inc. | 81.59M | 3.03% | 115,250 | 47.40M |
370 | IGMS | IGM Biosciences, Inc. | 81.56M | -0.37% | 7,564 | 2.68M |
371 | CBUS | Cibus, Inc. | 80.13M | 0.59% | 18,225 | 4.75M |
372 | IMUX | Immunic, Inc. | 80.01M | -0.33% | 77,149 | - |
373 | MGX | Metagenomi, Inc. | 78.50M | -4.98% | 165,436 | 45.26M |
374 | VANI | Vivani Medical, Inc. | 77.61M | 3.15% | 65,647 | - |
375 | EPIX | ESSA Pharma Inc. | 76.35M | -1.71% | 1,777 | - |
376 | VRCA | Verrica Pharmaceuticals Inc. | 76.05M | -5.77% | 28,768 | 7.18M |
377 | IMMX | Immix Biopharma, Inc. | 75.62M | 0.18% | 56,103 | - |
378 | GUTS | Fractyl Health, Inc. | 73.46M | -1.32% | 5,030 | 60.00K |
379 | PYXS | Pyxis Oncology, Inc. | 72.79M | -1.26% | 5,673 | 16.15M |
380 | ADAP | Adaptimmune Therapeutics plc | 72.46M | -0.33% | 39,615 | 179.64M |
381 | KLTO | Klotho Neurosciences, Inc. | 72.20M | -6.16% | 1,608,918 | - |
382 | GNTA | Genenta Science S.p.A. | 71.33M | - | - | - |
383 | SRZN | Surrozen, Inc. | 70.87M | -3.42% | 101 | 11.64M |
384 | ANEB | Anebulo Pharmaceuticals, Inc. | 70.67M | -2.82% | 1 | - |
385 | ANRO | Alto Neuroscience, Inc. | 70.12M | 0.39% | 9,250 | - |
386 | IPA | ImmunoPrecise Antibodies Ltd. | 70.02M | -8.11% | 456,877 | 16.58M |
387 | CNTB | Connect Biopharma Holdings Limited | 70.01M | 9.57% | 44,816 | 26.03M |
388 | VTGN | Vistagen Therapeutics, Inc. | 69.83M | -1.44% | 22,071 | 486.00K |
389 | INO | Inovio Pharmaceuticals, Inc. | 69.81M | -1.44% | 426,963 | 283.10K |
390 | CLSD | Clearside Biomedical, Inc. | 69.15M | 1.64% | 14,254 | 3.76M |
391 | STRO | Sutro Biopharma, Inc. | 68.88M | -0.28% | 15,407 | 66.43M |
392 | RPTX | Repare Therapeutics Inc. | 67.17M | 0.38% | 831 | 1.07M |
393 | JUNS | Jupiter Neurosciences, Inc. | 65.88M | 4.19% | 237,160 | - |
394 | UNCY | Unicycive Therapeutics, Inc. | 65.73M | -0.95% | 20,505 | - |
395 | IRD | Opus Genetics, Inc. | 65.63M | -1.79% | 17,073 | 13.65M |
396 | IKNA | Ikena Oncology, Inc. | 65.15M | -2.88% | 9,853 | - |
397 | PMVP | PMV Pharmaceuticals, Inc. | 64.94M | -1.57% | 3,596 | - |
398 | QNTM | Quantum BioPharma Ltd. | 64.40M | -2.22% | 12,909 | - |
399 | CRVO | CervoMed Inc. | 63.79M | 1.66% | 22,569 | 9.31M |
400 | ABVC | ABVC BioPharma, Inc. | 63.38M | 16.42% | 304,508 | 508.38K |
401 | MNOV | MediciNova, Inc. | 62.78M | 0.79% | 9,031 | - |
402 | IFRX | InflaRx N.V. | 62.23M | 2.61% | 8,483 | 140.24K |
403 | CNTX | Context Therapeutics Inc. | 61.00M | 1.48% | 2,374 | - |
404 | ICCC | ImmuCell Corporation | 59.56M | 1.07% | 350 | 27.30M |
405 | ACET | Adicet Bio, Inc. | 59.55M | -2.68% | 19,568 | - |
406 | INMB | INmune Bio, Inc. | 59.02M | -0.45% | 165,472 | 50.00K |
407 | SER | Serina Therapeutics, Inc. | 58.77M | - | 28 | 51.00K |
408 | PDSB | PDS Biotechnology Corporation | 58.28M | -1.92% | 109,448 | - |
409 | ATRA | Atara Biotherapeutics, Inc. | 57.25M | 1.29% | 1,658 | 199.73M |
410 | APLT | Applied Therapeutics, Inc. | 56.97M | -2.83% | 204,057 | 265.00K |
411 | ADVM | Adverum Biotechnologies, Inc. | 56.37M | -0.81% | 5,817 | 1.00M |
412 | SNTI | Senti Biosciences, Inc. | 56.07M | -7.33% | 7,275 | - |
413 | MAIA | MAIA Biotechnology, Inc. | 56.07M | -4.15% | 34,425 | - |
414 | FBIO | Fortress Biotech, Inc. | 55.89M | -5.03% | 52,627 | 57.78M |
415 | CUE | Cue Biopharma, Inc. | 55.35M | -7.71% | 39,534 | 7.99M |
416 | IPSC | Century Therapeutics, Inc. | 54.94M | 3.15% | 29,474 | 114.90M |
417 | ANL | Adlai Nortye Ltd. | 54.61M | -1.99% | 115 | 1.94M |
418 | ANVS | Annovis Bio, Inc. | 53.98M | -2.81% | 47,145 | - |
419 | NRXP | NRx Pharmaceuticals, Inc. | 53.94M | -4.59% | 25,662 | - |
420 | ATHE | Alterity Therapeutics Limited | 53.92M | 23.65% | 104,181 | 2.30M |
421 | ALGS | Aligos Therapeutics, Inc. | 53.69M | -0.11% | 3,413 | 3.27M |
422 | JSPR | Jasper Therapeutics, Inc. | 52.80M | -0.99% | 99,947 | - |
423 | AVTX | Avalo Therapeutics, Inc. | 52.30M | -1.43% | 601 | 441.00K |
424 | GANX | Gain Therapeutics, Inc. | 51.73M | -1.13% | 17,621 | - |
425 | DTIL | Precision BioSciences, Inc. | 51.34M | -4.14% | 25,069 | 51.14M |
426 | RENB | Renovaro Inc. | 51.31M | 0.30% | 231,013 | - |
427 | CELU | Celularity Inc. | 51.01M | -1.39% | 8,833 | 54.22M |
428 | ITRM | Iterum Therapeutics plc | 50.00M | 15.74% | 330,509 | - |
429 | PRLD | Prelude Therapeutics Incorporated | 49.69M | -0.80% | 4,179 | 7.00M |
430 | NRSN | NeuroSense Therapeutics Ltd. | 49.18M | -2.84% | 1,859 | - |
431 | OSTX | OS Therapies Incorporated | 48.96M | -1.20% | 91,908 | - |
432 | HOWL | Werewolf Therapeutics, Inc. | 48.91M | 0.93% | 21,970 | 1.14M |
433 | KLRS | Kalaris Therapeutics, Inc. | 48.63M | 4.00% | 822 | - |
434 | RNXT | RenovoRx, Inc. | 47.91M | -2.24% | 6,975 | 240.00K |
435 | ATNM | Actinium Pharmaceuticals, Inc. | 47.73M | -1.29% | 27,633 | 81.00K |
436 | MRSN | Mersana Therapeutics, Inc. | 47.14M | -0.47% | 561,219 | 34.01M |
437 | ARTV | Artiva Biotherapeutics, Inc. | 44.10M | 1.12% | 99,967 | 251.00K |
438 | GRCE | Grace Therapeutics, Inc. | 43.42M | 1.29% | 949 | - |
439 | MURA | Mural Oncology plc | 42.65M | -0.60% | 1,426 | - |
440 | PLUR | Pluri Inc. | 42.11M | -1.11% | 115 | 1.03M |
441 | KALA | KALA BIO, Inc. | 42.07M | -5.51% | 15,329 | - |
442 | ACRV | Acrivon Therapeutics, Inc. | 41.86M | -1.11% | 8,437 | - |
443 | BRNS | Barinthus Biotherapeutics plc | 40.46M | -5.37% | - | 14.97M |
444 | PEPG | PepGen Inc. | 40.25M | -1.60% | 15,262 | - |
445 | XCUR | Exicure, Inc. | 40.12M | -12.77% | 713 | 500.00K |
446 | CGTX | Cognition Therapeutics, Inc. | 38.73M | -10.70% | 2,983,736 | - |
447 | RANI | Rani Therapeutics Holdings, Inc. | 37.98M | -0.05% | 11,472 | 1.20M |
448 | STTK | Shattuck Labs, Inc. | 37.22M | 0.35% | 2,769 | 4.61M |
449 | XLO | Xilio Therapeutics, Inc. | 37.03M | -3.87% | 54,261 | 9.27M |
450 | AKTX | Akari Therapeutics, Plc | 36.68M | -0.44% | 2,904 | - |
451 | KPTI | Karyopharm Therapeutics Inc. | 35.60M | -17.60% | 277,723 | 142.13M |
452 | PYPD | PolyPid Ltd. | 35.36M | - | 5,081 | - |
453 | LVTX | LAVA Therapeutics N.V. | 35.25M | -0.75% | - | 4.99M |
454 | LTRN | Lantern Pharma Inc. | 35.05M | -7.41% | 6,835 | - |
455 | QTTB | Q32 Bio Inc. | 35.01M | -13.55% | 1,245,902 | - |
456 | OKUR | OnKure Therapeutics, Inc. | 34.72M | 0.78% | 11,896 | - |
457 | RADX | Radiopharm Theranostics Limited | 34.15M | 1.43% | 6,004 | 204.61K |
458 | TELO | Telomir Pharmaceuticals, Inc. | 33.93M | -2.56% | 16,988 | - |
459 | COEP | Coeptis Therapeutics Holdings, Inc. | 33.42M | 0.11% | 3,680 | 62.87K |
460 | ESLA | Estrella Immunopharma, Inc. | 33.41M | - | - | - |
461 | RNTX | Rein Therapeutics Inc. | 32.79M | - | 25 | - |
462 | KZR | Kezar Life Sciences, Inc. | 32.51M | -7.10% | 82 | - |
463 | ANTX | AN2 Therapeutics, Inc. | 32.29M | - | 1,217 | - |
464 | IGC | IGC Pharma, Inc. | 32.09M | -7.83% | 1,820,907 | 1.27M |
465 | CAMP | Camp4 Therapeutics Corporation | 31.90M | 2.78% | 1,776 | 1.51M |
466 | ENLV | Enlivex Therapeutics Ltd. | 31.26M | -1.49% | 2,660 | - |
467 | FGEN | FibroGen, Inc. | 30.51M | 2.71% | 14,181 | 7.00M |
468 | TPST | Tempest Therapeutics, Inc. | 29.84M | -0.82% | 4,872 | - |
469 | DYAI | Dyadic International, Inc. | 29.79M | -0.99% | 591 | 3.55M |
470 | OVID | Ovid Therapeutics Inc. | 29.21M | -1.96% | 63,489 | 548.00K |
471 | CLDI | Calidi Biotherapeutics, Inc. | 28.22M | -15.83% | 2,654,646 | - |
472 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 26.88M | 0.82% | 237,908 | - |
473 | ALXO | ALX Oncology Holdings Inc. | 26.73M | 0.62% | 19,412 | - |
474 | PBM | Psyence Biomedical Ltd. | 26.72M | 0.83% | 1,454 | - |
475 | BOLD | Boundless Bio, Inc. | 26.64M | 0.85% | 22,700 | - |
476 | PASG | Passage Bio, Inc. | 26.09M | 5.61% | 17,640 | - |
477 | CALC | CalciMedica, Inc. | 25.99M | 14.81% | 4,713 | - |
478 | GBIO | Generation Bio Co. | 25.67M | 2.71% | 174,823 | 24.56M |
479 | GDTC | CytoMed Therapeutics Limited | 25.39M | - | - | 368.84K |
480 | CVKD | Cadrenal Therapeutics, Inc. | 25.37M | -0.77% | 2,871 | - |
481 | FBLG | FibroBiologics, Inc. | 25.29M | -0.71% | 34,400 | - |
482 | CVM | CEL-SCI Corporation | 24.75M | 26.18% | 6,759,642 | - |
483 | NRXS | NeurAxis, Inc. | 23.67M | 3.11% | 12,823 | 2.93M |
484 | PULM | Pulmatrix, Inc. | 23.52M | - | 10 | 1.92M |
485 | BCAB | BioAtla, Inc. | 22.87M | 1.27% | 13,378 | 11.00M |
486 | SLGL | Sol-Gel Technologies Ltd. | 22.81M | 0.98% | 714 | 12.10M |
487 | OSRH | OSR Holdings, Inc. | 22.75M | -2.48% | 28,940 | -148.95K |
488 | CMMB | Chemomab Therapeutics Ltd. | 22.61M | 1.72% | 28,817 | - |
489 | SABS | SAB Biotherapeutics, Inc. | 22.53M | -3.02% | 747 | 377.84K |
490 | LGVN | Longeveron Inc. | 22.51M | - | 13,903 | 2.23M |
491 | NNVC | NanoViricides, Inc. | 22.50M | -0.72% | 12,651 | - |
492 | VYNE | VYNE Therapeutics Inc. | 22.50M | -2.17% | 7,238 | 605.00K |
493 | ELEV | Elevation Oncology, Inc. | 22.36M | -0.32% | 40,867 | - |
494 | LSTA | Lisata Therapeutics, Inc. | 22.36M | -5.11% | 3,838 | 1.00M |
495 | PTIX | Protagenic Therapeutics, Inc. | 22.20M | -3.74% | 60,780 | - |
496 | DARE | Daré Bioscience, Inc. | 21.86M | 3.35% | 6,731,308 | 25.91K |
497 | RLMD | Relmada Therapeutics, Inc. | 21.64M | -2.72% | 5,325 | - |
498 | MLEC | Moolec Science SA | 21.43M | -7.45% | 4,089 | 7.83M |
499 | CRIS | Curis, Inc. | 21.07M | 4.36% | 1,129 | 11.20M |
500 | LSB | LakeShore Biopharma Co., Ltd | 20.99M | 2.80% | 45,457 | 79.42M |
501 | CASI | CASI Pharmaceuticals, Inc. | 20.45M | -7.69% | 1,050 | 31.37M |
502 | BLRX | BioLineRx Ltd. | 20.05M | -3.48% | 2,408 | 22.34M |
503 | MRKR | Marker Therapeutics, Inc. | 19.92M | -2.17% | 33,781 | 5.70M |
504 | APUS | Apimeds Pharmaceuticals US, Inc. | 19.79M | -5.52% | 1,777 | - |
505 | HOTH | Hoth Therapeutics, Inc. | 19.48M | -1.01% | 105,413 | - |
506 | CING | Cingulate Inc. | 18.47M | -1.81% | 2,453 | - |
507 | MEIP | MEI Pharma, Inc. | 18.22M | 1.67% | 673 | - |
508 | ARTL | Artelo Biosciences, Inc. | 17.95M | -7.89% | 20,838 | - |
509 | CLGN | CollPlant Biotechnologies Ltd. | 17.93M | - | 458 | 2.47M |
510 | CTXR | Citius Pharmaceuticals, Inc. | 17.90M | -1.75% | 33,522 | - |
511 | PSTV | Plus Therapeutics, Inc. | 17.51M | -2.17% | 819,234 | 5.21M |
512 | EVAX | Evaxion A/S | 17.50M | 7.36% | 161,854 | 3.29M |
513 | LEXX | Lexaria Bioscience Corp. | 17.26M | -1.56% | 10,591 | 525.92K |
514 | LPCN | Lipocine Inc. | 17.07M | -3.92% | 7,387 | 3.67M |
515 | CARM | Carisma Therapeutics, Inc. | 17.01M | 2.29% | 209,707 | 19.96M |
516 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 16.94M | 1.33% | 64,939 | 1.00M |
517 | ATHA | Athira Pharma, Inc. | 16.49M | 0.32% | 24,222 | - |
518 | ASBP | Aspire Biopharma Holdings, Inc. | 16.38M | -3.29% | 360,881 | - |
519 | COCP | Cocrystal Pharma, Inc. | 16.18M | 1.27% | 2,589 | - |
520 | RLYB | Rallybio Corporation | 15.95M | -3.18% | 70,582 | 848.00K |
521 | HOOK | HOOKIPA Pharma Inc. | 15.71M | 0.81% | 7,184 | 9.35M |
522 | CANF | Can-Fite BioPharma Ltd. | 15.62M | -1.45% | 10,447 | 674.00K |
523 | ALLR | Allarity Therapeutics, Inc. | 15.38M | -5.56% | 98,186 | - |
524 | PTHS | Pelthos Therapeutics Inc. | 15.34M | -12.20% | 32,475 | - |
525 | GOVX | GeoVax Labs, Inc. | 14.77M | -3.99% | 120,376 | 5.59M |
526 | NEUP | Neuphoria Therapeutics Inc. | 14.56M | 1.88% | 3,641 | 15.66M |
527 | EDSA | Edesa Biotech, Inc. | 14.54M | - | - | - |
528 | LPTX | Leap Therapeutics, Inc. | 14.53M | -1.30% | 47,550 | - |
529 | LYRA | Lyra Therapeutics, Inc. | 14.35M | -0.94% | 7,682 | 1.19M |
530 | ERNA | Ernexa Therapeutics Inc. | 14.28M | -2.02% | 1,649 | 535.00K |
531 | MTVA | MetaVia Inc. | 14.10M | 0.28% | 9,732 | - |
532 | PRTG | Portage Biotech Inc. | 14.06M | 0.82% | 1,374 | - |
533 | IMNN | Imunon, Inc. | 14.04M | 1.37% | 186,818 | - |
534 | SYBX | Synlogic, Inc. | 14.04M | -3.23% | 103 | 8.00K |
535 | BCTX | BriaCell Therapeutics Corp. | 13.86M | -1.45% | 652,521 | - |
536 | BIVI | BioVie Inc. | 13.59M | - | 4,342 | - |
537 | PMN | ProMIS Neurosciences, Inc. | 13.40M | 1.86% | 7,405 | - |
538 | XTLB | XTL Biopharmaceuticals Ltd. | 13.29M | 2.30% | - | 451.00K |
539 | EQ | Equillium, Inc. | 13.22M | 6.26% | 130,107 | 30.41M |
540 | IBIO | iBio, Inc. | 12.86M | -3.88% | 49,784 | 375.00K |
541 | MBRX | Moleculin Biotech, Inc. | 12.77M | -0.77% | 706,565 | - |
542 | NXTC | NextCure, Inc. | 12.76M | -2.82% | 5,700 | - |
543 | EVGN | Evogene Ltd. | 12.58M | -2.76% | 9,149 | 6.77M |
544 | BCDA | BioCardia, Inc. | 12.27M | -2.07% | 42 | 3.00K |
545 | BRTX | BioRestorative Therapies, Inc. | 12.12M | 0.94% | 1,835 | 391.00K |
546 | BTAI | BioXcel Therapeutics, Inc. | 12.11M | - | 13,395 | 1.85M |
547 | LIXT | Lixte Biotechnology Holdings, Inc. | 11.88M | 2.13% | 111,089 | - |
548 | BCLI | Brainstorm Cell Therapeutics Inc. | 11.81M | -1.64% | 21,455 | - |
549 | KAPA | Kairos Pharma, Ltd. | 11.79M | -1.55% | 25,535 | - |
550 | BOLT | Bolt Biotherapeutics, Inc. | 11.79M | -2.69% | 107 | 3.64M |
551 | ABP | Abpro Holdings, Inc. | 11.76M | -0.62% | 541,302 | 183.00K |
552 | ACXP | Acurx Pharmaceuticals, Inc. | 11.62M | -0.79% | 24,887 | - |
553 | NERV | Minerva Neurosciences, Inc. | 11.54M | 0.61% | 16 | - |
554 | CYCN | Cyclerion Therapeutics, Inc. | 11.43M | 0.28% | 187 | 2.08M |
555 | TAOX | TAO Synergies Inc. | 11.41M | 2.76% | 478,883 | - |
556 | PHIO | Phio Pharmaceuticals Corp. | 11.32M | -3.48% | 6,741 | - |
557 | KZIA | Kazia Therapeutics Limited | 11.29M | -2.51% | 11,116 | 1.55M |
558 | SNSE | Sensei Biotherapeutics, Inc. | 11.22M | -2.20% | 157 | - |
559 | APVO | Aptevo Therapeutics Inc. | 11.04M | -1.00% | 9,475 | - |
560 | CSCI | COSCIENS Biopharma Inc. | 10.99M | - | - | 9.03M |
561 | MBIO | Mustang Bio, Inc. | 10.94M | -6.72% | 224,757 | - |
562 | PHGE | BiomX Inc. | 10.73M | - | 6,918 | - |
563 | IMRN | Immuron Limited | 10.29M | 0.28% | 883 | 4.05M |
564 | APRE | Aprea Therapeutics, Inc. | 10.21M | 4.24% | 751 | 1.28M |
565 | TCRT | Alaunos Therapeutics, Inc. | 9.65M | -1.08% | 2,967 | 11.00K |
566 | ICU | SeaStar Medical Holding Corporation | 9.60M | -3.08% | 905,104 | 428.00K |
567 | AEON | AEON Biopharma, Inc. | 9.50M | -2.27% | 15,128 | - |
568 | DWTX | Dogwood Therapeutics, Inc. | 9.36M | -1.80% | 1,872 | - |
569 | KPRX | Kiora Pharmaceuticals, Inc. | 9.28M | 1.33% | 3,683 | 20.00K |
570 | CLRB | Cellectar Biosciences, Inc. | 9.10M | 1.83% | 10,816 | - |
571 | XFOR | X4 Pharmaceuticals, Inc. | 8.86M | -2.55% | 21,518 | 31.36M |
572 | TRAW | Traws Pharma, Inc. | 8.71M | -0.32% | 7,342 | 227.00K |
573 | TSBX | Turnstone Biologics Corp. | 8.47M | -0.65% | 1,838 | - |
574 | GNPX | Genprex, Inc. | 8.21M | -2.68% | 86,578 | - |
575 | CELZ | Creative Medical Technology Holdings, Inc. | 8.05M | 8.71% | 601,050 | 14.00K |
576 | INAB | IN8bio, Inc. | 7.75M | -1.75% | 13,981 | - |
577 | INTS | Intensity Therapeutics, Inc. | 7.69M | -3.07% | 359,184 | - |
578 | ADXN | Addex Therapeutics Ltd | 7.62M | 1.23% | 113 | 278.51K |
579 | PMCB | PharmaCyte Biotech, Inc. | 7.58M | 0.67% | 817 | - |
580 | THAR | Tharimmune, Inc. | 7.56M | 1.40% | 2,899 | - |
581 | HCWB | HCW Biologics Inc. | 7.53M | -2.26% | 2,208 | 1.45M |
582 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.46M | - | 1,130 | 19.90K |
583 | INDP | Indaptus Therapeutics, Inc. | 7.43M | 5.19% | 504 | - |
584 | RNAZ | TransCode Therapeutics, Inc. | 7.42M | -1.11% | 2,261 | - |
585 | GTBP | GT Biopharma, Inc. | 7.18M | -0.45% | 3,014 | - |
586 | NLSP | NLS Pharmaceutics AG | 7.04M | -0.54% | 8,371 | - |
587 | IBO | Impact BioMedical Inc. | 6.93M | 0.16% | 76,065 | - |
588 | PPBT | Purple Biotech Ltd | 6.85M | - | 1 | - |
589 | SLXN | Silexion Therapeutics Corp | 6.65M | -4.31% | 48,453 | - |
590 | APM | Aptorum Group Limited | 6.44M | -3.01% | 2,808 | - |
591 | CYCC | Cyclacel Pharmaceuticals, Inc. | 6.43M | -3.31% | 7,311 | 14.00K |
592 | APLM | Apollomics, Inc. | 6.40M | 1.75% | 1,908 | 198.00K |
593 | ADIL | Adial Pharmaceuticals, Inc. | 6.01M | -7.07% | 344,749 | - |
594 | PCSA | Processa Pharmaceuticals, Inc. | 5.85M | -2.91% | 1,229,256 | - |
595 | XBIO | Xenetic Biosciences, Inc. | 5.83M | -1.29% | 2,200 | 2.58M |
596 | QLGN | Qualigen Therapeutics, Inc. | 5.82M | 1.14% | 1,203 | - |
597 | CDT | Conduit Pharmaceuticals Inc. | 5.60M | -3.32% | 19,014 | - |
598 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.30M | - | 2 | - |
599 | MTNB | Matinas BioPharma Holdings, Inc. | 5.19M | -0.97% | 2,066 | - |
600 | VIVS | VivoSim Labs, Inc. | 5.17M | 1.02% | 463 | 144.00K |
601 | TTNP | Titan Pharmaceuticals, Inc. | 5.12M | -0.27% | 4,999 | - |
602 | KTTA | Pasithea Therapeutics Corp. | 5.07M | -1.42% | 9,974 | - |
603 | ATNF | 180 Life Sciences Corp. | 5.03M | -0.10% | 3,691 | - |
604 | CMND | Clearmind Medicine Inc. | 4.98M | -1.09% | 12,162 | - |
605 | CNSP | CNS Pharmaceuticals, Inc. | 4.86M | -1.92% | 5,759 | - |
606 | DRMA | Dermata Therapeutics, Inc. | 4.59M | 0.04% | 6,528 | - |
607 | GLMD | Galmed Pharmaceuticals Ltd. | 4.58M | - | 55,375 | - |
608 | SILO | Silo Pharma, Inc. | 4.53M | -0.02% | 28,165 | 72.10K |
609 | GLTO | Galecto, Inc. | 4.51M | -1.73% | 231 | - |
610 | TOVX | Theriva Biologics, Inc. | 4.26M | 0.11% | 22,365 | - |
611 | SNGX | Soligenix, Inc. | 4.15M | - | 32,815 | 2.34K |
612 | AZTR | Azitra, Inc. | 4.09M | -6.06% | 34,670 | 7.50K |
613 | VRAX | Virax Biolabs Group Limited | 3.90M | 1.03% | 952 | 6.33K |
614 | GRI | GRI Bio, Inc. | 3.85M | 3.74% | 20,497 | - |
615 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.81M | -0.96% | 4,347 | 802.32K |
616 | PALI | Palisade Bio, Inc. | 3.74M | -0.13% | 2,809 | - |
617 | PLRZ | Polyrizon Ltd. | 3.68M | -3.63% | 14,388 | - |
618 | SPRC | SciSparc Ltd. | 3.64M | -1.59% | 312 | 1.31M |
619 | NBY | NovaBay Pharmaceuticals, Inc. | 3.57M | -5.48% | 2,368 | 9.78M |
620 | JAGX | Jaguar Health, Inc. | 3.42M | -1.90% | 2,940 | 11.55M |
621 | CERO | CERo Therapeutics Holdings, Inc. | 3.41M | -0.11% | 13,350 | - |
622 | ENVB | Enveric Biosciences, Inc. | 3.36M | 0.72% | 16,151 | - |
623 | ENSC | Ensysce Biosciences, Inc. | 3.34M | -2.87% | 13,528 | 6.22M |
624 | XRTX | XORTX Therapeutics Inc. | 3.15M | 0.69% | 2,172 | - |
625 | ELAB | PMGC Holdings Inc. | 3.09M | -1.10% | 6,141 | 2.45M |
626 | ZVSA | ZyVersa Therapeutics, Inc. | 2.83M | -1.73% | 183,778 | - |
627 | WINT | Windtree Therapeutics, Inc. | 2.56M | 7.69% | 615,494 | - |
628 | BDRX | Biodexa Pharmaceuticals Plc | 2.56M | -0.49% | 24,817 | 104.90K |
629 | ADTX | Aditxt, Inc. | 2.54M | -1.64% | 47,893 | 55.32K |
630 | ONCO | Onconetix, Inc. | 2.31M | 1.14% | 5,066 | 1.93M |
631 | ALZN | Alzamend Neuro, Inc. | 2.28M | 1.64% | 15,033 | - |
632 | ENTO | Entero Therapeutics, Inc. | 2.19M | -5.54% | 74,510 | - |
633 | SCNI | Scinai Immunotherapeutics Ltd. | 2.06M | -3.91% | 4,623 | 658.00K |
634 | REVB | Revelation Biosciences, Inc. | 1.91M | -0.33% | 38,947 | - |
635 | UBX | Unity Biotechnology, Inc. | 1.74M | -36.88% | 1,010,722 | - |
636 | SLRX | Salarius Pharmaceuticals, Inc. | 1.70M | 2.70% | 9,654 | - |
637 | TNFA | TNF Pharmaceuticals, Inc. | 1.60M | -3.33% | 539,640 | - |
638 | OGEN | Oragenics, Inc. | 1.17M | -2.74% | 16,995 | - |
639 | NCNA | NuCana plc | 356.76K | -1.34% | 48,292,106 | - |